3,6,9,12,15,18,21-Heptaazahexacosa-3,6,9,12,15,18,21-heptaene-1,26-diimidic acid, 2,14-bis[3-[(aminoiminomethyl)amino]propyl]-23-[[(2S)-2-[[(2S)-2-[[4-[(E)-2-[4-(dimethylamino)phenyl]diazenyl]benzoyl] ;amino]-1-hydroxy-4-methylpentylidene]amino]-1-hydroxypropylidene]amino]-4,7,10,13,16,19,22-heptahydroxy-5,8,11-tris(hydroxymethyl)-20-methyl-17-(1-methylethyl)-N-[2-[(5-sulfo-1-naphthalenyl)amino]e thyl]-, (2S,5S,8S,11S,14S,17S,20S,23S)-
|
(2S,5S,8S,11S,14S,17S,20S,23S)-2,14-Bis(3-carbamimidamidopropyl)-23-{[(2S)-2-({(2S)-2-[(4-{(E)-[4-(dimethylamino)phenyl]diazenyl}benzoyl)amino]-1-hydroxy-4-methylpentylidene}amino)-1-hydroxypropyliden ;e]amino}-4,7,10,13,16,19,22-heptahydroxy-5,8,11-tris(hydroxymethyl)-17-isopropyl-20-methyl-N-{2-[(5-sulfo-1-naphthyl)amino]ethyl}-3,6,9,12,15,18,21-heptaazahexacosa-3,6,9,12,15,18,21-heptaene-1,26- ;diimidic acid
|
DABCYL-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg-EDANS
|
TACE FRET Substrate I
|